Is there a way to boost immunotherapy response?
Molecular biologist Kevin Barry, PhD, received a $270,000, two-year grant from the American Cancer Society to investigate new ways to boost immunotherapy responses against metastatic melanoma. Barry’s research explores the ways that tumor microenvironment helps cancer cells evade the immune system. With this grant, Barry hopes to develop new therapies that repair the immune system’s ability and response to cancer cells, which will ultimately improve patient responses and outcomes.
Media contact: Molly McElroy, mwmcelro@fredhutch.org
Oncology Insights with Dr. Petros Grivas – Episode 11
Host Petros Grivas, MD, PhD, FASCO, speaks with Lei Deng, MD, about the advances in lung cancer research and patient care. Deng discusses how precision medicine, immunotherapy and rapid molecular testing are improving outcomes for patients with the disease, as well as the importance of early detection, team-based care and delivering treatment that reflects patients’ values and priorities.
Media contact: Heather Platisha, hplatisha@fredhutch.org
Oncology Insights with Dr. Petros Grivas – Episode 12
Host Petros Grivas, MD, PhD, FASCO, is joined by Stanley Riddell, MD, a world leader in the field of immunotherapy and professor emeritus of Fred Hutch’s Translational Science and Therapeutics Division. They discuss how Riddell helped shape the field’s progress, and the landscape of changes from transplantation to T-cell therapies that are transforming cancer treatment.
Media contact: Molly McElroy, mwmcelro@fredhutch.org